Author

Helen V. Alderson

Observed names: Alderson, Helen, Alderson, Helen V., H. Alderson, H., Alderson, H.V. Alderson, Helen Alderson, Helen V Alderson

Institution: Salford Royal NHS Foundation Trust

Observed institutions: Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, University of Manchester, Salford Royal Hospital, NIHR Manchester Biomedical Research Centre, Northern Care Alliance NHS Foundation Trust

OpenAlex ID: A5028151317

The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase–Associated Lipocalin with Progression from CKD to ESRD

2016 · Helen V. Alderson, James P. Ritchie, et al. · Clinical Journal of the American Society of Nephrology · 55

Extreme Elevations in Blood Pressure and All‐Cause Mortality in a Referred CKD Population: Results from the CRISIS Study

2013 · James Ritchie, Francesco Rainone, et al. · International Journal of Hypertension · 42

PDF

FGF‐23 and Osteoprotegerin but not Fetuin‐A are associated with death and enhance risk prediction in non‐dialysis chronic kidney disease stages 3–5.

2015 · Helen V Alderson, James P Ritchie, et al. · Nephrology · 30

The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease

2019 · Lynne Sykes, Ozgur Asar, et al. · PLoS ONE · 27

PDF

Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease

2015 · James Ritchie, Darren Green, et al. · Nephrology · 26

Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease

2015 · James Ritchie, Darren Green, et al. · Journal of the American Society of Hypertension · 24

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

2021 · Helen Eddington, Rajkumar Chinnadurai, et al. · BMC Nephrology · 21

PDF

Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease

2017 · Jeffrey X. Xie, Helen Alderson, et al. · Scientific Reports · 21

PDF

Safely reducing haemodialysis frequency during the COVID-19 pandemic

2020 · Michelle Da Silva Lodge, Thilini Abeygunaratne, et al. · BMC Nephrology · 15

PDF

Where now in the management of renal artery stenosis? Implications of the ASTRAL and CORAL trials

2014 · James Ritchie, Helen V. Alderson, et al. · Current Opinion in Nephrology & Hypertension · 15

Functional Status and Mortality in Chronic Kidney Disease: Results from a Prospective Observational Study

2014 · James P. Ritchie, Helen Alderson, et al. · Nephron Clinical Practice · 13

An exploration of patients’ experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rule

2017 · Patricia van den Berg, Sarah Kendal, et al. · Emergency Medicine Journal · 11

PDF

Potential for Biomarkers of Chronic Kidney Disease-Mineral Bone Disorder to Improve Patient Care

2013 · H.V. Alderson, J.P. Ritchie, et al. · Nephron Clinical Practice · 10

Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbidity

2023 · Saif Al-Chalabi, Helen Alderson, et al. · BMJ Open Quality · 7

PDF

Revascularization as a treatment to improve renal function

2014 · Philip (Phil) Kalra, Helen Alderson, et al. · International Journal of Nephrology and Renovascular Disease · 6

PDF

Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease

2025 · Senthil K. Vasan, Rajkumar Chinnadurai, et al. · American Journal of Nephrology · 4

PDF

Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease

2021 · Helen V. Alderson, Rajkumar Chinnadurai, et al. · BMC Nephrology · 4

PDF

Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular disease

2019 · Diana Vassallo, Helen Alderson, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 3

Preoperative Radiotherapy for Operable Rectal Cancer — Is a Lower Dose to a Reduced Volume Acceptable?

2006 · M.P. Saunders, H. Alderson, et al. · Clinical Oncology · 3

Shifting Sands or ANCA-ed in Place? The Epidemiology of ANCA-Associated Vasculitis over 2 Decades at a Large Tertiary Centre

2025 · Joshua Storrar, Sawangchit Launiyomchon, et al. · Glomerular Diseases · 1

PDF

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?

2025 · Han Sean Lee, Henry H. L. Wu, et al. · Antibodies · 1

An Eye to the Future: Development of a Metabolic-Renal-Cardiac (MRC) Service

2022 · Saif Al-Chalabi, Saira Nawaz, et al. · Journal of the American Society of Nephrology · 1

Associations Between Initial Presentation of Multiple Myeloma and Renal Function: the Experience of Two European Centers

2016 · Francesco Rainone, Sayyid M. Ammar Raza, et al. · Journal of Hematology · 1

Ischaemic nephropathy

2015 · Helen Alderson, Constantina Chrysochou, et al. · Oxford University Press eBooks · 1

Rapidly progressive glomerulonephritis in rheumatoid arthritis: an early presentation of ANCA-associated vasculitis